Lusutrombopag

FDA Drug Profile — Mulpleta

Lusutrombopag is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand name including Mulpleta. Available dosage forms: powder, tablet, film coated.

Drug Details

Generic Name
Lusutrombopag
Brand Names
Mulpleta
Application Number
NDA210923
Sponsor
Shionogi Pharma Co., Ltd.
NDC Codes
4
Dosage Forms
POWDER, TABLET, FILM COATED
Routes
ORAL
Active Ingredients
LUSUTROMBOPAG

Indications and Usage

1 INDICATIONS AND USAGE MULPLETA is indicated for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure. MULPLETA is a thrombopoietin receptor agonist indicated for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure. ( 1 )